About nferreyros

This author has not yet filled in any details.
So far nferreyros has created 5 blog entries.

Community Oncology Alliance: 2018 Year in Review

Introduction In 2018, the assault on patient access to local and affordable cancer care provided by community oncologists, upon which over half of all Americans rely, continued. The work of the Community Oncology Alliance (COA) repelled, repealed, or slowed down a record number of significant challenges to patients and practices, including proposed cuts to

By |2022-09-01T13:29:11-04:00February 6th, 2019|Annual & Mid-Year Reports, Member Updates, News & Updates|Comments Off on Community Oncology Alliance: 2018 Year in Review

The Myth of Perverse Physician Incentives: Examining Research and Accusations in the Medicare Part B ASP Reimbursement System for Oncology

A frequent accusation aimed at physicians who prescribe and administer medications within the Medicare Part B system is that they are motivated by a perverse incentive of higher reimbursement to prescribe expensive drugs. For oncologists, who utilize potentially life-saving, but increasingly very expensive drugs in treating some of the nation’s sickest patients, this is a

By |2018-12-31T14:03:15-05:00December 31st, 2018|Research & Publications|Comments Off on The Myth of Perverse Physician Incentives: Examining Research and Accusations in the Medicare Part B ASP Reimbursement System for Oncology

COA Comments on IPI for Medicare Part B Drugs

The Honorable Seema Verma, Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-5528-ANPRM P.O. Box 8016 Baltimore, MD 21244-8013 Re: Medicare Program; International Pricing Index Model for Medicare Part B Drugs; CMS-5528- ANPRM Dear Administrator Verma: On behalf of the Board of Directors of the Community Oncology Alliance

By |2022-12-27T10:28:13-05:00December 31st, 2018|Comment Letters|Comments Off on COA Comments on IPI for Medicare Part B Drugs

COA Comments Objecting to CVS-Aetna Merger

Peter Mucchetti, Esq. Peter.J.Mucchetti@usdoj.gov Antitrust.atr@usdoj.gov Chief, Healthcare and Consumer Products Section, Antitrust Division, Department of Justice 450 Fifth Street NW, Suite 4100 Washington, DC 20530 RE: United States of America v. CVS Health Corporation and Aetna Inc. Dkt. No.: 1:18-cv-02340 Dear Mr. Mucchetti: The Community Oncology Alliance (“COA”) submits this letter on behalf of

By |2022-09-01T13:25:14-04:00December 16th, 2018|Comment Letters|Comments Off on COA Comments Objecting to CVS-Aetna Merger

COA needs your support for 2019!

We are about to enter a critical period for community oncology. Far-reaching Medicare policies are under consideration in Washington that have the potential to completely transform your practice and, quite possibly, ability to survive. From the way you and your practice are reimbursed; to how you acquire and deliver complex cancer drugs; to your ability

By |2022-09-01T13:29:13-04:00November 29th, 2018|Member Updates|Comments Off on COA needs your support for 2019!